These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16351602)
1. Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients. Ascić-Buturović B; Cavaljuga S Bosn J Basic Med Sci; 2005 Nov; 5(4):68-71. PubMed ID: 16351602 [TBL] [Abstract][Full Text] [Related]
2. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy. Piwowar A; Knapik-Kordecka M; Buczyńska H; Warwas M Arch Immunol Ther Exp (Warsz); 1999; 47(5):327-31. PubMed ID: 10604239 [TBL] [Abstract][Full Text] [Related]
3. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Mojiminiyi OA; Abdella N; George S Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064 [TBL] [Abstract][Full Text] [Related]
5. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324 [TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. Xia LH; Bing XG; An XT J Clin Lab Anal; 2004; 18(1):31-5. PubMed ID: 14730555 [TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952 [TBL] [Abstract][Full Text] [Related]
8. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Oddoze C; Morange S; Portugal H; Berland Y; Dussol B Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157 [TBL] [Abstract][Full Text] [Related]
9. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis. Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708 [TBL] [Abstract][Full Text] [Related]
10. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy. Lee BW; Ihm SH; Choi MG; Yoo HJ Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797 [TBL] [Abstract][Full Text] [Related]
11. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes. Yang YS; Peng CH; Lin CK; Wang CP; Huang CN Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370 [TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682 [TBL] [Abstract][Full Text] [Related]
13. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus? El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834 [TBL] [Abstract][Full Text] [Related]
14. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?]. Peczyńska J; Urban M; Głowińska B; Florys B Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367 [TBL] [Abstract][Full Text] [Related]
15. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018 [TBL] [Abstract][Full Text] [Related]
16. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy. Pavkov ME; Knowler WC; Hanson RL; Williams DE; Lemley KV; Myers BD; Nelson RG Am J Kidney Dis; 2013 Jul; 62(1):33-41. PubMed ID: 23347458 [TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. Shimizu A; Horikoshi S; Rinnno H; Kobata M; Saito K; Tomino Y J Clin Lab Anal; 2003; 17(5):164-7. PubMed ID: 12938144 [TBL] [Abstract][Full Text] [Related]
18. Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects. Buysschaert M; Joudi I; Wallemacq P; Hermans MP Diabetes Metab; 2003 Sep; 29(4 Pt 1):377-83. PubMed ID: 14526265 [TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes. Kalansooriya A; Holbrook I; Jennings P; Whiting PH Br J Biomed Sci; 2007; 64(3):121-3. PubMed ID: 17910281 [TBL] [Abstract][Full Text] [Related]
20. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes. Jeon YL; Kim MH; Lee WI; Kang SY Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]